Status:
UNKNOWN
The Effect of Bright Light Therapy on Migraine With Sleep Disturbance
Lead Sponsor:
Hungkuang University
Conditions:
Migraine
Sleep Disturbance
Eligibility:
FEMALE
20-65 years
Phase:
NA
Brief Summary
Migraine is a common disabling disorder and its substantial burden is associated with considerable negative impact on quality of life. Several pharmacological treatments are available for migraine pro...
Detailed Description
Migraine is a common disabling disorder and its substantial burden is associated with considerable negative impact on quality of life. Several pharmacological treatments are available for migraine pro...
Eligibility Criteria
Inclusion
- The criteria for participation will be women:
- who aged between 20 and 65 years old.
- with a history of migraine headache and poor sleep quality (screen by using PSQI: Pittsburgh Sleep Quality Index).
- willing to participate for 9 weeks data collection, including self-reported questionnaires, monitor sleep (7-days wrist actigrpy and overnight polysomnography), and blood sample.
- not allergic to metal, which would be a contradiction for wearing the wrist actigraph.
Exclusion
- Women will be excluded from participation for any of the following:
- have a history of trauma brain injury.
- history of alcoholism in the past year.
- pregnant or breastfeeding women.
- sensitive to light.
- history of using the following medicine in the past month: beta-blockers, antiepileptic, calcium ion blockers, antidepressants, hormone therapy.
Key Trial Info
Start Date :
June 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 14 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04890691
Start Date
June 15 2021
End Date
June 14 2023
Last Update
May 18 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.